Updated on 2024/04/03

写真a

 
UETSUKI Kota
 
Organization
Nagoya University Hospital Gastroenterology Assistant professor of hospital
Title
Assistant professor of hospital
 

Papers 7

  1. Endoscopic ultrasound-guided drainage using a forward-viewing echoendoscope for peripancreatic fluid collection after Child resection

    Ishikawa, T; Yamao, K; Mizutani, Y; Iida, T; Uetsuki, K; Nakamura, M; Kawashima, H

    ENDOSCOPY   Vol. 56 ( S 01 ) page: E83 - E84   2024.12

     More details

    Language:English   Publisher:Endoscopy  

    DOI: 10.1055/a-2234-4075

    Web of Science

    Scopus

    PubMed

  2. An atypical case of isolated immunoglobulin G4-related sclerosing cholangitis with a cholangiogram resembling primary sclerosing cholangitis

    Takada, Y; Ishikawa, T; Yamao, K; Mizutani, Y; Iida, T; Uetsuki, K; Kawashima, H

    CLINICAL JOURNAL OF GASTROENTEROLOGY   Vol. 17 ( 2 ) page: 338 - 344   2024.4

     More details

    Language:English   Publisher:Clinical Journal of Gastroenterology  

    An asymptomatic 77-year-old man with intrahepatic bile duct dilation was referred to our hospital. Cholangiography revealed alternations between strictures and dilated segments from the right and left hepatic ducts to the lower bile ducts, with findings of a pruned tree, beaded, shaggy appearance, and diverticulum-like outpouching. Histopathology revealed abundant immunoglobulin G4 (IgG4)-positive plasma cells (> 10 per high-power field) with an IgG4/IgG-positive cell ratio of 40–50%. After 2 weeks of steroid therapy, the cholangiography markedly improved. Because the cholangiographic findings resembled those of primary sclerosing cholangitis, steroid therapy proved useful in differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.

    DOI: 10.1007/s12328-023-01903-w

    Web of Science

    Scopus

    PubMed

  3. Outcomes of endoscopic papillectomy of ampullary carcinoma and factors affecting additional surgery

    Takada, Y; Ishikawa, T; Yamao, K; Mizutani, Y; Iida, T; Uetsuki, K; Gibo, N; Ohno, E; Kawashima, H

    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES   Vol. 31 ( 2 ) page: 110 - 119   2024.2

     More details

    Language:English   Publisher:Journal of Hepato-Biliary-Pancreatic Sciences  

    Background/Purpose: Data on the prognosis of endoscopic papillectomy (EP) for ampullary carcinoma (AC) is limited; therefore, we aimed to identify the factors associated with endoscopically controlled AC. Methods: Between January 2003 and October 2022, 75 patients underwent EP for ampullary tumors and were diagnosed with AC based on the pathological features of the resected tissue. The factors associated with additional surgery after EP were also evaluated. Results: A total of 67 patients had ACs ranging from carcinoma in situ to tumors limited to the mucosa (M group), and eight patients had ACs ranging from those limited to the sphincter of Oddi to those invading the duodenal muscularis propria (OD group). The 3-year endoscopic tumor control (condition not requiring additional surgery) rates in the M and OD groups were 90.8% and 84.6% (p =.033), respectively. In the M group, the presence of tumor components in the resection margins was the only significant factor associated with additional surgeries (p =.010) in the univariate analysis. The 3-year endoscopic tumor control rates were 100% for negative and uncertain resection margins and 76.6% for positive margins (p =.009). Conclusions: If the AC is confined to the mucosa and the resection margins are negative or uncertain, the tumor can be well-controlled endoscopically.

    DOI: 10.1002/jhbp.1375

    Web of Science

    Scopus

    PubMed

  4. Current status of and future issues related to endoscopic papillectomy

    Kawashima, H; Ishikawa, T; Yamao, K; Mizutani, Y; Iida, T; Uetsuki, K; Yamamura, T; Furukawa, K; Nakamura, M

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 85 ( 4 ) page: 648 - 658   2023.11

     More details

    Language:English   Publisher:Nagoya Journal of Medical Science  

    Endoscopic papillectomy is widely performed to treat duodenal papillary tumors, particularly at highvolume centers. It is indicated for adenomas without intraductal extension of the bile or pancreatic ducts. However, despite numerous reports of carcinomas that expand the indications to include well-differentiated adenocarcinomas that do not invade the sphincter of Oddi, the low agreement between biopsy and final pathological diagnosis, as well as the current inability of imaging modalities to diagnose sphincter of Oddi invasion, makes it difficult to consider expanding indications. Although complications can be prevented by certain methods, such as pancreatic duct stenting, and the frequency of severe complications has decreased, the safety of the procedure remains unconfirmed. In the future, this technology is expected to progress and enable wider applications, including those in tumors with extensive horizontal spread and those with intraductal extension of the bile and pancreatic ducts. Such technology may also improve the safety and accuracy of diagnosis.

    DOI: 10.18999/nagjms.85.4.648

    Web of Science

    Scopus

    PubMed

  5. Clinical Features and Long-term Prognosis of Type 1 Autoimmune Pancreatitis Based on the Location of Biliary Stenosis

    Ishikawa Takuya, Yamao Kentaro, Mizutani Yasuyuki, Iida Tadashi, Uetsuki Kota, Gibo Noriaki, Kataoka Kunio, Mori Hiroshi, Takada Yoshihisa, Aoi Hironori, Minami Yoshiyuki, Kawashima Hiroki

    Tando   Vol. 37 ( 4 ) page: 754 - 762   2023.10

     More details

    Language:Japanese   Publisher:Japan Biliary Association  

    <p>We compared the clinical features and long-term prognosis of 159 patients with type 1 autoimmune pancreatitis (AIP) with and without bile duct involvement. Eighty-nine (56%) patients had bile duct involvement. Forty-nine patients (30.8%) had relapse, with a significantly higher cumulative relapse rate in patients with stenosis or wall thickening upstream of the intrapancreatic bile duct (3 years: 24% vs. 37.1%, <i>P</i><0.001). A significantly higher rate of two or more relapses (5.1% vs. 19.5%, <i>P</i>=0.01) was also found in these patients. Two patients with stenosis/dilatation up to the intrahepatic bile ducts became steroid-dependent and were treated with azathioprine. Type 1 AIP patients with stenosis and wall thickening upstream of the intrapancreatic bile ducts have a high relapse rate and may become steroid-dependent, especially in cases with stenosis and dilation extending into the intrahepatic bile ducts.</p>

    DOI: 10.11210/tando.37.754

    CiNii Research

  6. 症例報告 特発性細菌性腹膜炎を合併した急性膵炎後の皮下結節性脂肪壊死症の1例

    天野 友里恵, 桃原 真理子, 竹内 想, 河野 通浩, 秋山 真志, 倉田 信彦, 植月 康太

    臨床皮膚科   Vol. 77 ( 11 ) page: 921 - 925   2023.10

     More details

    Publisher:株式会社医学書院  

    DOI: 10.11477/mf.1412207126

    CiNii Research

  7. A case of multiple myeloma with plasmacytoma in the gallbladder and pancreas

    Gibo Noriaki, Nonogaki Koji, Ohno Eizaburo, Aoki Toshinori, Yashika Jun, Uetsuki Kota, Iida Tadashi, Mizutani Yasuyuki, Yamao Kentaro, Ishikawa Takuya, Uno Yusuke, Kawashima Hiroki

    Tando   Vol. 37 ( 1 ) page: 83 - 90   2023.3

     More details

    Language:Japanese   Publisher:Japan Biliary Association  

    <p>An 84-year-old man presented to our hospital with back pain and loss of appetite, and was noted to have hypercalcemia, renal failure, and hyperproteinemia. The patient was diagnosed with multiple myeloma following bone marrow aspiration. Contrast-enhanced computed tomography revealed an irregular mass that was slightly contrast-enhanced in the gallbladder neck. A round mass with the same contrast effect was also noted in the pancreatic tail, right thoracic cavity, and abdominal cavity. Endoscopic ultrasonography showed that the gallbladder lesion was irregular hypoechoic mass combined with high and low echoes and the pancreatic tail lesions was irregular hypoechoic mass with clear contours. Fine needle aspiration under endoscopic ultrasonography was conducted on both lesions and showed plasma cells with atypia in both samples and were ultimately diagnosed as plasmacytoma. First-line bortezomib-melphalan-prednisone therapy had no response, and an obstructive jaundice associated with the growth of the gallbladder mass developed. However, second-line lenalidomide-dexamethasone therapy that was initiated after bile duct stenting showed a decrease in the M protein and improvement in hypercalcemia. Moreover, the gallbladder lesion and pancreatic lesion were reduced in size, which were consistent with the clinical course of plasmacytoma.</p>

    DOI: 10.11210/tando.37.83

    CiNii Research

▼display all